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ARTICLE
Rational design of a microbial consortium of
mucosal sugar utilizers reduces Clostridiodes
difficile colonization
Fátima C. Pereira 1, Kenneth Wasmund1, Iva Cobankovic2, Nico Jehmlich 3, Craig W. Herbold1,
Kang Soo Lee 4,5, Barbara Sziranyi1, Cornelia Vesely6, Thomas Decker 7, Roman Stocker 4,5,
Benedikt Warth 2, Martin von Bergen3, Michael Wagner1,8 & David Berry 1,9✉
Many intestinal pathogens, including Clostridioides difficile, use mucus-derived sugars as
crucial nutrients in the gut. Commensals that compete with pathogens for such nutrients are
therefore ecological gatekeepers in healthy guts, and are attractive candidates for therapeutic
interventions. Nevertheless, there is a poor understanding of which commensals use mucin-
derived sugars in situ as well as their potential to impede pathogen colonization. Here, we
identify mouse gut commensals that utilize mucus-derived monosaccharides within complex
communities using single-cell stable isotope probing, Raman-activated cell sorting and mini-
metagenomics. Sequencing of cell-sorted fractions reveals members of the underexplored
family Muribaculaceae as major mucin monosaccharide foragers, followed by members of
Lachnospiraceae, Rikenellaceae, and Bacteroidaceae families. Using this information, we
assembled a five-member consortium of sialic acid and N-acetylglucosamine utilizers that
impedes C. difficile’s access to these mucosal sugars and impairs pathogen colonization in
antibiotic-treated mice. Our findings underscore the value of targeted approaches to identify
organisms utilizing key nutrients and to rationally design effective probiotic mixtures.
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Host-derived compounds constitute a reliable nutrientsource for gut microbes1–3, and can be especiallyimportant for sustaining members of the gut microbiota
when diet-derived nutrients become scarce4–6. The mucus layer
that covers the mammalian intestinal epithelium constitutes a
source of carbon and nitrogen for gut bacteria7–10. Highly gly-
cosylated mucins are the dominant structural component of
mucus, with O-glycan carbohydrates making up to 80% of the
total mucin mass11. Secreted mucin O-glycans have different core
structures composed of N-acetylgalactosamine (GalNAc), N-
acetylglucosamine (GlcNAc), and galactose residues, which can
be further extended with galactose, GlcNAc, GalNAc, fucose or
sialic acid (N-acetylneuraminic acid; NeuAc or Neu5Ac) sugar
residues, with the latter two frequently occupying terminal
positions12–15 (Fig. 1a). The ability of gut bacteria to degrade
whole mucin O-glycan structures has been characterized in cul-
tivated gut organisms including representative species from
Bacteroides, Bifidobacterium, Akkermansia and Ruminococcus14.
Genomic analysis of available human gut bacterial genomes has
predicted that 86% of the 397 analyzed organisms possess the
capability to cleave, and 89% to catabolize, at least one of the
mucin O-glycan monosaccharides14,15. Therefore, the genomic
potential to catabolize these compounds is widespread among
genomes of gut organisms. However, it is not known which of the
organisms harboring the necessary catabolic pathways are key
mucosal sugar foragers within the context of natural gut micro-
bial communities, where complex ecological processes may
influence the use of different substrates by distinct organisms.
Further, it is unclear whether preferences towards particular
monosaccharides in O-glycans exist among commensal gut
members, as is the case for some pathogens.
In addition to commensals, the ability to utilize mucin glycans
or particular mucin-derived monosaccharides as a source of
nutrients confers a competitive advantage to several gut patho-
gens16–19. Clostridioides difficile is an important nosocomial
pathogen that benefits from host-derived compounds, such as the
mucosal sugars NeuAc and GlcNAc, to colonize the gut and cause
severe intestinal infections17,19–22. C. difficile is also able to cat-
abolize another mucosal sugar, galactose, though galactose utili-
zation has not been implicated as an important factor for C.
difficile colonization19,22. Depletion of the indigenous microbiota
by antibiotic treatment is the major risk factor for C. difficile
infection (CDI)23,24, and microbiota restoration via fecal micro-
biota transplantation is currently the most successful way of
treating CDI25. Mechanisms through which the indigenous
microbiota provides resistance to C. difficile colonization include:
(i) production of inhibitory substances such as thuricidin or
reuterin26–28, (ii) transformation of bile acids29,30, and (iii)
depletion or transformation of host and diet-derived
nutrients17,21,31,32. Individual strains or a mixture of four
strains that provide partial restoration of colonization resistance
to CDI via some of the mechanisms described above have been
identified28–30,33. However, no bacteriotherapy mixture able to
limit C. difficile use of mucosal sugars has been documented
to date.
Here we employ deuterium (D) stable isotope probing com-
bined with Raman-activated cell sorting (RACS) and metage-
nomics to identify organisms that can forage on O-glycan
monosaccharides in the mouse gut. This approach allows us to
non-destructively track microbial activity at the single-cell level in
response to a variety of compounds, thereby enabling post-
measurement molecular analysis, and has been successfully
employed in the past to identify foragers of host-derived proteins
from the mouse gut34,35. Applying this recently developed tech-
nique, we identified a number of bacterial taxa as generalists in
regard to mucosal sugar foraging, being able to utilize all the
different O-glycan sugars, as well as taxa that seem to be spe-
cialized on only a subset of the available mucosal sugars. With
this new information, we designed a bacteriotherapy mixture
based on the organisms identified as active NeuAc and GlcNAc
foragers and evaluated the impact of their presence on C. difficile
growth in mice. We show that this bacterial consortium is able to
decrease the availability of these mucosal sugars and can reduce
C. difficile growth both in vitro and in vivo. Our approach
therefore identified a consortium of gut bacteria that contributes
to colonization resistance against C. difficile, and further indicates
that depletion of mucosal sugars is one of the mechanisms
underpinning this resistance.
Results
Tracking microbial activity in response to mucin O-glycan
monosaccharides. To investigate the utilization of mucin O-
glycan monosaccharides (NeuAc, GlcNAc, fucose, galactose, and
GalNAc) by colonic microbiota, freshly collected mouse colon
microbiota samples were incubated ex vivo with different con-
centrations of each of the mucosal O-glycan monosaccharides
individually, or mucin itself, in the presence of 50% heavy water
(D2O) under anaerobic conditions at 37 °C (Fig. 1a). Based on a
preliminary experiment to determine the most suitable time point
to efficiently probe for D incorporation, an incubation period of
6 h was selected for all subsequent incubations (Supplementary
Fig. 1). Final concentrations of different mucosal mono-
saccharides supplemented to the microcosms were in the low
millimolar range (between 3 and 28mM; Fig. 1c bottom panel).
The lowest concentration values were selected based on reported
concentrations of the different monosaccharides in purified hog
gastric mucin and mucin gels36,37 and on the typical O-glycan
structure of the large intestine, i.e., sugars such as galactose and
GlcNAc are more abundant than are GalNAc or the terminal
residues fucose and NeuAc38. Cells stimulated by each supple-
mented monosaccharide become active and as a result incorpo-
rate D into cellular constituents such as lipids or proteins, which
can be effectively detected by single-cell Raman microspectro-
scopy34. This approach was applied to cells from supplemented
microcosms of three independent experiments (MonoA, MonoB,
and MonoC; see “Methods”). Amendment of all mucosal sugars
(in separate experiments) resulted in activity-induced D incor-
poration (measured as %CD34) into cells above threshold levels,
while cells from control microcosms that were exposed to deut-
erated water but not supplemented with sugars showed only
negligible levels of D incorporation (Fig. 1b, c). The lowest per-
centage of cells showing D incorporation was observed for
amendments with 3 mM fucose (9.4 ± 2.9%) and the highest for
cells supplemented with 28 mM of galactose (73.8 ± 8.5%)
(Fig. 1b, c). When D incorporation levels were compared among
treatments with similar concentrations of each compound (5-
6 mM), galactose resulted in D incorporation by the largest
fraction of cells within the community (62.5 ± 5%; p= 0.005,
ANOVA) in comparison to the other sugars (Fig. 1c, inset chart).
These results are in agreement with the fact that a larger number
of gut organisms encode enzymatic pathways for galactose cata-
bolism, with NeuAc, fucose and GalNAc catabolism pathways
being less prevalent among gut bacteria15. Quantification of
mucosal sugars in the microcosms revealed that microbial-
mediated conversion led to depletion of a significant fraction
(12–70%) of the monosaccharides when compared to abiotic
controls (p= 4.809e−06, Mann–Whitney test; Fig. 1d). Never-
theless, we observed no correlation between the fraction of sugar
consumed and the levels of D incorporation (%CD) or the per-
centage of D-labeled cells (Fig. 1b–d). This suggests that other
factors such as the amount of energy gained from the catabolism
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of each of these compounds, the different physiologies of the taxa
involved in their degradation and/or possible conversion of
sugars into storage compounds may play an important role in
their biosynthetic activities.
In an attempt to gain initial insights into the identities of the
active cells, we analyzed initial and supplemented microcosms by
16S rRNA gene amplicon sequencing over-time. Members of the
phyla Bacteroidota and Firmicutes, and of the families Lachnos-
piraceae, Muribaculaceae (formerly classified as Bacteroidales
S24-7 family) and Bacteroidaceae dominated the initial bacterial
community in our microcosm experiments and no significant
shifts in the community composition were detected during
incubation (Fig. 1e, f). Rather, the community composition
cluster by experiment (p < 0.001, r2= 0.132, PERMANOVA;
Fig. 1f), which can be attributed to differences in the composition
of the mouse colon microbiota contents used in different
incubations. Furthermore, no significant clustering of the
bacterial community by sugar supplemented was observed,
indicating that the short incubation time used was able to limit
the expansion of stimulated organisms (Fig. 1f). Because activity
measurements using D and Raman spectroscopy do not require
cell division34, this approach allowed us to conclude that a
significant part of the mouse colon microbiota uptakes, and as
result becomes active, upon amendment with different mucosal
O-glycan monosaccharides, with response to galactose being the
most prominent.
Sorting, sequencing, and identification of O-glycan mono-
saccharide utilizers. In order to identify the organisms involved
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cells from the supplemented microcosms using RACS and
shotgun-sequenced DNA from collected cells (Supplementary
Fig. 2c,d). Between 125 and 244 cells were sorted for each
amendment, yielding the recovery of 23–43 metagenome-
assembled genomes (MAGs) per amendment (Fig. 2a, Supple-
mentary Table 1). No MAGs were recovered from sorts from
two negative controls consisting of microcosms incubated with
glucose in the absence of D (GlucH). MAGs represented a total
of 51 unique population genomes (as defined by sharing an
average nucleotide identity39, ANI < 99%), including 9 near-
complete genomes and 24 substantially complete genomes
(Supplementary Data 1). They belonged predominantly to the
phyla Bacteroidota and Firmicutes, with a small number
belonging to the phyla Verrucomicrobiota, Proteobacteria,
Desulfobacterota and Patescibacteria (Fig. 2a, Supplementary
Fig. 3, Supplementary Data 1). A large percentage (43%) of the
retrieved MAGs belonged to the family Muribaculaceae, a result
supported by previous studies that identified members of this
family as potential mucus degraders34,35,40. Several organisms
were recovered from amendments with at least four out of the
five individual monosaccharides, as well as from mucin
amendments (11 top MAGs; Fig. 2a). We defined these taxa as
“mucosal sugar generalists” (further discussed in the “Discus-
sion” section).
To discard the possibility that the pool of generalist organisms
we identified was not simply influenced by the high relative
abundances of these organisms in the microcosms, we deter-
mined the initial relative abundance of sorted organisms prior to
sorting. Metagenomic sequencing of initial microcosms allowed
us to retrieve 120 MAGs (named “MMAGs” for Microcosm
MAG; Supplementary Data 1), of which, 44 overlapped with
RACS-retrieved MAGs (ANI > 99%) (Supplementary Fig. 3,
Supplementary Table 2). Calculation of relative abundances
(based on read coverage) of generalist organisms revealed that 5
out of 11 were present at low relative abundances (below 1%) in
the initial microcosms (Fig. 2a). Mucosal-sugar generalists
identified here belonged almost exclusively to the order Bacteroi-
dales or to the family Lachnospiraceae, supporting previous
predictions from genomic analyses that reported Bacteroidetes
and Clostridia as major mucin generalists from the human gut15.
Enzymatic hydrolysis of different mucosal sugars, as well as
canonical pathways for catabolism of cleaved monosaccharides,
have been described and identified for a subset of human gut
microbes15. To further evaluate the success of our approach in
selecting organisms involved in mucosal sugar utilization upon
mucin breakdown, sorted fractions as well as the unsorted initial
microcosms were queried for the presence of genes encoding
enzymes involved in mucosal sugar uptake35 (Supplementary
Table 3). We detected an enrichment of up to four-fold for genes
involved in mucin degradation in the sorted fractions compared
with unsorted metagenomes. Overall, the screened genes were
twice as abundant in sorted fractions (P= 0.0247, one-sample t
test), and all the genes screened were enriched in these fractions
with the sole exception of an alpha-galactosidase (Supplementary
Table 3).
We further analyzed the genomic potential of the individual
sorted organisms identified by RACS to catabolize different O-
glycan sugars. To this end, we screened all sorted MAGs for the
presence of enzymes involved in the hydrolysis and catabolism of
the respective sugar monosaccharides (i.e., each MAG was
screened for a specific catabolic pathway only if it was recovered
from amendments of that particular monosaccharide: 108 MAG-
monosaccharide combinations were screened). Despite the fact
that retrieved MAGs consisted of incompletely reconstructed
genomes, we could identify complete or near-complete catabo-
lism pathways (with the exception of GalNAc) in many (48%) of
the MAG-monosaccharide combinations. For 82% of the MAG-
monosaccharide combinations screened, we identified at least one
enzyme involved in the catabolism and/or cleavage of the
respective monosaccharide (Fig. 2b; Supplementary Data 2),
though we could not identify any organisms that encoded
enzymes for a complete GalNAc catabolism pathway in our
dataset. Further, the large majority of MAGs (19 out of 25)
recovered from GalNAc amendments do not encode any of the
known enzymes necessary for the canonical catabolism of this
monosaccharide, notwithstanding the presence of cleavage
enzymes (Fig. 2b; Supplementary Data 2).
Cross-validation of D incorporation into RACS-sorted taxa
using SIP-metaproteomics. To corroborate the D-labeling of
organisms sorted and identified by RACS, we performed meta-
proteomic analyses to identify incorporation of D into peptides
produced by members of the gut microbiota41. To this end, we
Fig. 1 Application of D2O to identify active mucin monosaccharide utilizers. a Experimental setup. Mouse colon contents were diluted in PBS and
supplemented with indicated compounds; T0 refers to microcosms processed immediately after establishment. After an incubation period of 6 h, cells from
all microcosms were processed as described in the “Methods” section, and subsequently probed for D incorporation by Raman microspectroscopy or
sorted based on their incorporated D levels by RACS. Sorted cells were processed for sequencing. b Deuterium incorporation (measured by %CD) of
randomly selected cells. Boxes represent median, first and third quartile. Whiskers extend to the highest and lowest values that are within one and a half
times the interquartile range. c Average percentage of cells labeled (i.e., with %CD higher than threshold) per microcosm. Bars represent average and
standard deviation of independent experiments. The red horizontal line at 2.36 %CD indicates the threshold for considering a cell labeled. It was
determined by calculating the mean + 3SD of %CD in randomly selected cells from sample GlucH, in which cells were incubated without addition of heavy
water. Different concentrations of compound supplemented to each microcosms are shown below the horizontal axis (c). Asterisk indicates the GlucH
sample. Insert chart shows a direct comparison of the percentage of labeled cells in microcosms supplemented with comparable concentrations of each
mucosal monosaccharide (5–6mM) (*p= 0.005; one-way ANOVA). All cells measured from two independent experiments are depicted in (b) and
average percentages from both experiments are depicted in (c). d Percentage of supplemented mucosal monosaccharide utilized in three independent
microcosms per condition, established with live (gray boxes) or autoclaved (white boxes) biomass. Initial and final (after 6 h) concentrations of compounds
were quantified using HILIC for microcosms supplemented with the highest concentration of each compound tested in (c). Boxes represent median, first
and third quartile. Whiskers extend to the highest and lowest values that are within one and a half times the interquartile range (*p= 0.0360; **p=
0.0038; ***p= 0.0008 for galactose, NeuAc and fucose, respectively, or ***p= 0.0006 for GalNAc; ns=non-significant; two-tailed Welch two-sample
t test). e Initial microcosms composition (family level) determined by 16S rRNA gene amplicon sequencing from three independent experiments (MonoA, B
and C). f Variation between samples (Principal Coordinates Analysis based on Bray–Curtis dissimilarities) colored by the monosaccharide supplemented
for 3 independent experiments. For each experiment, the initial time point before supplement (T0) and the final time point after incubation (6 h) with each
supplemented monosaccharide are represented. The percentage in brackets correspond to the variation explained by each principal coordinate (PCo) to
the fraction of the total variance of the data. Source data are provided as a Source Data file.
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analyzed peptides from all microcosms using high-resolution
mass spectrometry and quantified the relative isotope abundance
(RIA) of D in retrieved peptides. A custom-made database con-
sisting of protein-encoding sequences recovered from the
MMAGs was used for peptide identification. Between 6,808 and
16,676 total unique peptides were identified from different sup-
plemented microcosms (Supplementary Table 4). Of these, a low
but significant percentage was shown to have incorporated D
compared to no-amendment controls (Fig. 3a). The lowest per-
centage of identified peptides with incorporated D (0.36 ± 0.03%)
was detected for NeuAc-supplemented microcosms and the
highest (3.1 ± 2.5%) for mucin-supplemented microcosms
(Fig. 3a). The majority of the D-labeled peptides matched pro-
teins with housekeeping functions and/or which were involved in
central metabolism pathways, though we also detected D
incorporation into peptides matching O-glycan degradation-
specific proteins (Supplementary Table 5). Similar average levels
of incorporated D into labeled peptides were found across all
supplemented microcosms, which may be due to the short
incubation times used in our experiments (Fig. 3b). Members of
the Lachnospiraceae, Muribaculaceae, Bacteroidaceae and Rike-
nellaceae families dominated total metaproteomes (i.e., unlabeled
and D-labeled peptides) of supplemented microcosms. The rela-
tive abundance levels of peptides from these groups strongly
depended on the experiment (Mono-A, -B, or -C) (Fig. 3c), which
is in agreement with 16S rRNA amplicon sequencing analysis
(Fig. 1f). Importantly, the family level profiles of D-labeled pep-
tides differed from that of the total identified peptides, and were
dominated by members of the family Muribaculaceae (Fig. 3d).
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Fig. 2 Targeted mini-metagenomics of monosaccharide-utilizing bacteria from the mouse colon microbiota. a Identity of all MAGs recovered from
sequencing of RACS-sorted fractions. Color shades denote the bacterial phylum to which the MAG belongs. Filled circles denote from which amendment
each MAG has been recovered. MAGs recovered from different sorted fractions but with an ANI > 99% were considered to be the same, and a
representative was selected based on dRep analysis62. Completeness (red bars) and contamination (purple bars) calculated with CheckM60 are shown for
each representative MAG. The relative abundance (calculated based on metagenome coverage) of each MAG in the initial microcosms is indicated by gray
bars. For some RACS-MAGs relative initial abundances could not be calculated (not available-NA) because no corresponding MMAG was retrieved from
the microcosms metagenome. b genome-encoded O-glycan-cleavage and catabolic capability of monosaccharide-stimulated RACS organisms. Heatmap
showing the percentage of enzymes involved in the hydrolysis (glycoside hydrolases: GH) and the completeness of known catabolic pathways (catabolism
enzymes: C) of each compound (Supplementary Data 2). Only MAG-monosaccharide combinations that were recovered by RACS-sorting are depicted.
MAG-monosaccharide combinations that have not been recovered are shown in gray. Source data are provided as a Source Data file.
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RACS-derived results, in which the most common sorted
organisms belonged to the Muribaculaceae (Fig. 2a). Further-
more, by comparing the distribution of peptides from the dif-
ferent MAGs in the D-labeled peptide fraction with the total
peptides, we observed that peptides belonging to sorted MAGs
had comparatively higher contributions to the D-labeled peptide
pool than the total peptide pool. In 68% of the cases, we could
detect an enrichment of peptides from a particular MAG in the
D-labeled peptide fraction of the corresponding treatment from
which it was recovered (Fig. 3e; p < 0.05, Two-proportion Z-test).
Of note, 72% (18 out of 25) of the MAGs recovered from GalNAc
amendments were enriched in the D-labeled peptide pool com-
pared to the total peptide pool (Fig. 3e), despite that fact that
none of these MAGs encoded enzymes for canonical pathways for
catabolism of GalNAc (see “Discussion”). These results confirm
that the organisms retrieved by RACS were indeed D-labeled.
Depletion of NeuAc and GlcNAc by selected commensals
reduces C. difficile growth in vitro. The pathogen C. difficile
upregulates genes encoding enzymes involved in the uptake of
NeuAc and GlcNAc during gut colonization19,21,22. In line with
these findings, such facilitated access to NeuAc increases C. dif-
ficile colonization levels in vivo, and genetic inactivation of the
NeuAc transporter is associated with impaired pathogen coloni-
zation17. These observations prompted us to investigate whether
commensal NeuAc and GlcNAc utilizers identified here could
efficiently deplete these mucosal sugars, and by doing so, reduce C.
difficile growth and/or colonization. We selected a bacterial con-
sortium among identified NeuAc and/or GlcNAc utilizers based
on the following premises: (i) their genomes contain complete
GlcNAc and/or NeuAc catabolism pathways (Supplementary
Data 2); (ii) a pure culture is available (or that of a closely related
organism; Supplementary Table 2); and (iii) the selected organ-
isms would cover as much as possible the phylogenetic diversity of
the GlcNAc and NeuAc utilizers identified (i.e., cover 3 out of the
5 phyla identified by sorting; Supplementary Fig. 3). We therefore
selected a 5-member consortium (“BacMix” for bacteriotherapy
mixture) that includes the following organisms: Akkermansia
muciniphila type strain Muc, Ruthenibacterium lactatiformans
type strain 585-1, Alistipes timonensis type strain JC136, Mur-
ibaculum intestinale type strain YL27, and Bacteroides sp. isolate
FP24 (Supplementary Fig. 3; see Methods).
To address if the BacMix consortium was able to compete with
C. difficile for NeuAc and GlcNAc, we grew C. difficile in a diluted
rich medium without (A II medium) or with (A II medium+
sugars) NeuAc and GlcNAc as carbon/energy sources, and




































































































































































































































































































































































































Fig. 3 Deuterium incorporation into peptides from O-glycan monosaccharide-supplemented microcosms. a Fraction of peptides with incorporated
deuterium per amendment obtained by dividing the number of peptides with incorporated D by the total number of peptides. Significantly higher
percentages are found for supplemented microcosms compared with the no-amendment control (*p= 0.030 for NeuAc; *p= 0.028 for galactose; *p=
0.049 for mucin; **p= 0.001 for GlcNAc and fucose; **p= 0.006 for GalNAc; one-tailed Welch two-sample t test using “None” as a reference group).
b Relative D abundance of D-labeled peptides from three different microcosms per condition (p= ns= non-significant; One-way ANOVA). In (a) and (b)
boxes represent median, first and third quartile. Whiskers extend to the highest and lowest values that are within one and a half times the interquartile
range. c, d Taxa assignment of total unique peptides (c) or deuterium labeled peptides (d) at the family level identified by metaproteomics analysis.
Taxonomic data from microcosms from three independent experiments is shown. e Heatmap showing the p-value significance level of enrichment of each
MMAG (equivalent to each RACS-MAG) in the D peptide pool compared to the total peptide pool (two-proportion Z-test). Only MAG-monosaccharide
combinations recovered by RACS-sorting are depicted. MAG-monosaccharide combinations that have not been recovered are shown in gray. Source data
are provided as a Source Data file.
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medium on C. difficile growth (Fig. 4a). This medium was able to
support growth of all BacMix strains and of C. difficile
independently, with the exception of R. lactatiformans (Supple-
mentary Fig. 4). Importantly, addition of GlcNAc and/or NeuAc
to the medium boosted bacterial growth so that higher final
optical densities (OD) were reached for all growing strains
(Supplementary Fig. 4). These results showed that the BacMix
members are efficient GlcNAc and/or NeuAc utilizers and that
these sugars are indeed able to sustain their growth. Strikingly,
significantly lower C. difficile titers were determined when the
BacMix consortium was pre-added to the medium containing
GlcNAc and NeuAc (Fig. 4b; right panel; t18: p= 0.0058, t21: p=
0.0516, Welch two-sample t test), though no significant reduction
due to the BacMix addition could be detected in the absence of
the sugars (Fig. 4b, left panel). This suggests that exhaustion of
these particular nutrient sources, but not of other components of
the basal medium, is able to impact C. difficile expansion. To
further test this hypothesis, we quantified the expression of C.
difficile genes previously shown to be critical for the catabolism of
NeuAc and/or GlcNAc (nanT, nagA, and nagB; targeting a
NeuAc transporter, an N-acetylneuraminate lyase and an N-
acetylglucosamine-6-phosphate deacetylase, respectively17,19)
during C. difficile growth in vitro by RT-qPCR at mid-
exponential phase (t18). As expected, only very low expression
levels of these genes were detected (relative to growth on diluted
A II medium supplemented with glucose) when C. difficile was
grown in the absence of sugars (Fig. 4c, left panel: A II medium).
Increased gene expression was observed after sugar amendment,
but this induction was significantly reduced for all three genes in
the presence of the BacMix (Fig. 4c, right panel: A II medium
+sugars). The decreased but measurable expression of genes for
NeuAc and/or GlcNAc catabolism suggests that C. difficile still
had access, albeit reduced, to these sugars. This, together with
access to alternative nutrient sources present in the basal medium
(e.g. amino acids), may explain the increase in C. difficile titers
over-time (from t18 to t21; Fig. 4b, right panel). Our results
therefore substantiate the capability of the BacMix consortium to
impact C. difficile growth by depleting NeuAc and/or GlcNAc.
Targeted microbiota restoration by a consortium of O-glycan
utilizers reduces C. difficile colonization levels in vivo. The
positive results obtained in vitro encouraged us to test whether
the BacMix consortium would also be able to impair C. difficile
colonization in vivo in conventional antibiotic-treated mice42. To
this end, antibiotic-treated mice were split into two groups, where
one group (BacMix group) received 5 × 106 BacMix cells by oral
gavage, while the other group (control group) received the vehicle
(PBS) alone (Fig. 5a). The next day, both groups were challenged
with 1 × 106 C. difficile cells by oral gavage (Fig. 5a). Microbiota
composition of both groups was monitored throughout the entire
experiment by 16S rRNA gene amplicon sequencing of fecal
pellets (Fig. 5b and Supplementary Fig. 5). As expected,
antibiotic-treatment induced a dramatic shift in the overall
microbiota composition (Fig. 5b, Bray–Curtis distance matrix,
day 0 and day 6), which was marked by expansion of Enter-
obacteriaceae and Burkholderiaceae (Supplementary Fig. 5a).
This was accompanied by a significant decrease in alpha diversity
(Supplementary Fig. 5b and c; p= 1.602e-06 for both Observed
Richness and Shannon Index metrics, Mann–Whitney test). No
significant clustering of microbiota by group could be observed at
this stage. However, we did observe a significant clustering of
mouse fecal microbiota by group following gavage (days 9 to 11;
p < 0.05, PERMANOVA analyses), which can be attributed to
differences in relative abundances of BacMix members such as
Akkermansiaceae (A. muciniphila), and Peptostreptococaceae
(C. difficile) between the two groups (Fig. 5b and Supplementary
Fig. 5a).
A closer look into the amplicon sequencing data allowed us to
identify OTUs 3, 5, 11, 34 and 81 as representatives of the BacMix
members A. muciniphila, R. lactatiformans, A. timonensis, M.
intestinale, and Bacteroides sp. isolate FP24, respectively. These
members were detected in the initial community (day 0) in both
groups of mice at low to moderate relative abundances (from 0.1
to 9.0%) and are depleted following antibiotic treatment (day 6;
Fig. 5c). All BacMix members, with the sole exception of M.
intestinale, were restored and detected in the guts of BacMix-
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Fig. 4 Targeted impairment of C. difficile growth by the BacMix consortium is accompanied by a decreased expression of NeuAc and GlcNAc
catabolism genes. a Optical density (OD) measurements of a BacMix culture, of a C. difficile culture or of a BacMix-C. difficile co-culture grown in diluted A
II medium supplemented (filled symbols) or not (open symbols) with NeuAc and GlcNAc. The arrow denotes the time of C. difficile inoculation (12 h). b C.
difficile CFU per ml of mono-culture (blue) or in a BacMix-C. difficile co-culture (brown) in medium non-supplemented (left panel) or supplemented (right
panel) with sugars. Boxes represent median, first and third quartile and whiskers represent minimum and maximum values from three different growth vials
per condition (**p= 0.0058, ns=non-significant; ns1: p= 0.0516; two-tailed Welch two-sample t test). c Induction of C. difficile nanA, nanT and nagB
expression in three independent growth vials collected at t18 from C. difficile mono cultures (blue) or BacMix-C. difficile co-cultures (brown) in diluted A II
medium not supplemented (left panel) or supplemented (right panel) with sugars, relative to growth in minimal medium containing 0.5% glucose (*p=
0.0118, **p= 0.0047, ns=non-significant; two-tailed Welch two-sample t test). d C. difficile nanT expression in fecal samples 2 days post-infection of
antibiotic-treated control (blue) or and BacMix-recipient (brown) mice relative to growth in minimal medium containing 0.5% glucose (n= 4/group)
(*p= 0.0021; two-tailed Welch two-sample t test). In (c, d), bars represent average and standard deviation and each data point is represented as a single
dot. Source data are provided as a Source Data file.
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R. lactatiformansM. intestinaleA. timonensis
Day
Fig. 5 Adoptive transfer of a BacMix consortium after antibiotic exposure of conventional mice increases resistance to C. difficile infection.
a Schematic representation of the in vivo adoptive transfer experiment. b Variation between samples based on 16S rRNA gene amplicon sequencing
((Principal Coordinates Analysis based on Bray–Curtis dissimilarities) colored by group and shaped by sampling day. The percentage in brackets
corresponds to the variation explained by each principal coordinate (PCo) to the fraction of the total variance of the data. c Relative abundance of the five
BacMix members in fecal samples collected from control (blue) and BacMix-recipient (brown) mice (n= 5/group) as inferred from 16S rRNA gene
amplicon sequencing. d, e Density of C. difficile at the indicated time points in feces of antibiotic-treated control (blue) and BacMix-recipient (brown) mice
determined by selective-medium plating (d) or by qPCR (e) (days 10 and 11: n= 10/group, days 9 and 13: n= 5/group). *p= 0.0155; **p= 0.0058; ns=
non-significant; two-sided Mann–Whitney test. In (c–e), boxes represent median, first and third quartile. Whiskers extend to the highest and lowest values
that are within one and a half times the interquartile range. Source data are provided as a Source Data file.
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the experiment), but not in the control group (Fig. 5c). Overall,
these results show that most of the BacMix members successfully
colonized the gut of inoculated mice. Nevertheless, the introduc-
tion of the 5-member consortium had no impact on alpha
diversity metrics, which remain the same across the two groups
throughout the entire experiment (Supplementary Fig. 5b, c).
To evaluate if the BacMix members were able to impair
C. difficile colonization, C. difficile levels in fecal pellets were
quantified throughout the experiment by CFU enumeration of
freshly collected and plated pellets and by qPCR using primers
targeting the C. difficile 16S rRNA gene. In line with previous
studies, C. difficile efficiently colonized the gut of antibiotic-
treated animals, reaching levels of >108 CFUs per gram of feces at
day 9 (1 day after infection) (Fig. 5d). No C. difficile could be
detected in the guts of mock-infected animals handled in parallel
(Supplementary Fig. 6). C. difficile titers in infected mice
stabilized (as assessed by CFU counts) or slightly increased (as
assessed by qPCR) until day 11 (day 3 post-infection) (Fig. 5d).
Remarkably, we observed a gradual decrease in the titers of
C. difficile in mice that received the BacMix compared with the
control group from day 9 to day 10. This difference is only
statistically significant at day 11, time point for which we detect a
notable decrease in C. difficile titers for the BacMix group (4.1 ±
4.6 × 107 cells per gram of feces) compared to the control group
(2.5 ± 2.1 × 108 cells per gram of feces) (Fig. 5d; p= 0.0058,
Mann–Whitney test). These results were further corroborated
using qPCR (Fig. 5e; p= 0.0155, Mann–Whitney test). At day 13
(day 5 post-infection) the titers of C. difficile in animals from both
groups start to decrease, suggesting that pathogen clearance from
the guts of these animals had already begun32. Furthermore, we
detected a significant decrease in C. difficile nanT expression
levels in mice from the BacMix group at day 2 post-infection
(normalized to the expression of the DNA polymerase IIIC gene),
indicating a reduction in the levels of available NeuAc in the guts
of these animals (Fig. 4d). We therefore conclude that the BacMix
consortium presented here colonizes the mouse gut of antibiotic-
treated mice and is capable of reducing C. difficile burdens
in vivo. This pathogen reduction can be explained at least in part
by an impaired access to mucosal sugars, particularly to NeuAc.
Importantly, we did not detect any significant impairment of C.
difficile colonization, nor a decrease in nanT expression, in mice
that received 5 × 106 cells of a control bacteriotherapy mix
(BacMixC; composed of equal numbers of Anaerotruncus
colihominis isolate FP23, Lactobacillus hominis strain DSM
23910 and of Escherichia sp. isolate FP11; Supplementary Table 2
and Supplementary Fig. 3) that were not detected among the
RACS-sorted cells from the incubations (Supplementary Fig. 7;
Supplementary Table 2).
Toxin-mediated intestinal inflammation is frequently observed
in the course of a CDI, and the severity of the inflammation
depends on the degree of virulence of the infecting C. difficile
strain, among other factors20,43. Histopathological examination of
colon sections from C. difficile colonized mice revealed only mild
pathology and no significant differences in terms of severity
between control and BacMix-recipient animals (Supplementary
Fig. 8a, b). Congruent with these results, we observed low but
quantifiable amounts of TcdB in C. difficile colonized animals
(between 37.4 and 238.3 ng of TcdB per g of colon content), but
no significant differences between groups (Supplementary Fig. 8c).
Furthermore, we recorded only minor weight loss in our
experiments (Supplementary Fig. 5d). These results are in
agreement with the low levels of cytotoxic activity reported for
C. difficile strain 630 in mice43,44.
Enhanced mucus degradation due to an overgrowth of mucus
utilizers has been reported to increase, rather than to decrease,
susceptibility to infection with the gut pathogen Citrobacter
rodentium4. However, we did not observe thinning of the mucus
layer, nor impairment of mucin secretion in mice that received
the BacMix compared to the control group (Supplementary
Fig. 9). We hypothesize that the administered BacMix
consortium expanded in the guts of these animals by using
the pool of free NeuAc and potentially other mucosal sugars,
carbohydrates or amino acids that became available after
antibiotic treatment17,45,46, rather than by over-degrading the
mucus layer.
Discussion
Experimental studies of mucin degradation by natural gut com-
munities have addressed mucin utilization as a whole, but have
not looked into the uptake of individual mucosal sugars by dif-
ferent taxa34,35. Here, we characterize for the first time the
capacity of the intestinal microbiota to forage on individual
mucosal sugars in the context of whole communities by exploit-
ing a recently developed activity-based Raman-sorter35. The large
majority of organisms identified here by single-cell deuterium
labeling showed genomic evidence for the capacity to use the
respective monosaccharide sugar and also became D-labeled in
their proteins, together strongly supporting their roles in mucosal
monosaccharide utilization. Several of the mucosal-sugar-
utilizing taxa identified in this study, i.e., Muribaculaceae,
Akkermansia, Bacteroides and Lachnospiraceae, have previously
been identified as potential mucus degraders, but their mono-
saccharide preferences in the context of a complex community
have not been investigated14,34. Our results therefore illuminate
the in situ nutrient niche of key mucosal sugar utilizers. Others,
such as Rikenellaceae (Alistipes species) (MAG RACS_006 and
026), are here reported for the first time as being directly involved
in mucosal sugar uptake (Fig. 2a; Supplementary Fig. 3). Inter-
estingly, Alistipes spp. have previously been proposed to live in
close association with the mucus, because their levels are
directly altered during epithelial inflammation47,48. Our results
indicate Alistipes spp. have the capacity to utilize various mucosal
derived sugars, which may therefore help to explain such
observations.
A number (11 of 51) of the identified mucosal sugar foragers,
i.e., Muribaculaceae, Bacteroidales, Alistipes and Lachnospiraceae,
are generalists that actively use all or most O-glycan mucosal
sugars (Fig. 2a). These organisms may be permanent mucus
residents and therefore take advantage of all available mucin
moieties as nutrient sources. However, the majority of the
organisms here identified were only sorted from one or two of the
mucosal sugars, and therefore may be more limited in their
capacities to use different sugars, or partly were low in abundance
and therefore might have been missed in some of the other
incubations by our cell-sorting approach (Fig. 2a). Despite the
high throughput of the RACS platform (up to 500 cells per
hour35), long sorting times are not possible for technical reasons
(i.e., sedimentation of cells over-time in the input microfluidics
and drifting of z-plane in the optics). To avoid these two technical
issues, we performed multiple 1–2 h sorting experiments for each
amendment/microcosm (Supplementary Table 1). We were able
to analyze on average 1000 cells per microcosm, a throughput
that is two orders of magnitude higher as achieved by manual
sorting34,35, which enabled us to identify major taxa of interest,
though possibly not sufficient for the recovery of extremely rare
organisms.
Few sorted organisms (4 out of 51), such as Alphaproteo-
bacteria, Desulfovibrio sp. and Prevotella sp. lack the genomic
potential to catabolize the sugars amended to the microcosms
they were sorted from and also tended to not be significantly
enriched in the D-labeled peptide pool (Fig. 2b and Fig. 3d).
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These organisms most likely became labeled and sorted due to
cross-feeding of metabolites released by primary utilizers, despite
the minimal incubation times employed. However, the majority
of the sorted organisms had the genome-encoded potential to
utilize the sugar supplemented to the microcosm from which it
was sorted, with the sole exception of GalNAc (Fig. 2b). Several
MAGs resulting from sorted cells from GalNAc amendments did
not contain genes for canonical GalNAc catabolic enzymes15
(Fig. 2b). However, several Bacteroides strains and Akkermansia
muciniphila are able to utilize GalNAc49,50, and also lack known
genes for the canonical GalNAc catabolic pathway15. We there-
fore propose that the GalNAc-supplemented sorted organisms
use an undescribed catabolic pathway for GalNAc. This finding
underlies the importance of applying function-targeted approa-
ches to identify organisms performing key functions in the gut
that would be otherwise missed by random genome-centric
approaches.
The function-targeted sorting of uncultured cells in this study
enabled us to identify key players in NeuAc and GlcNAc cata-
bolism, and to then rationally select a mixture of organisms
(BacMix) able to impair the growth of the pathogen C. difficile.
We observed that there was a consistent decrease of half a log in
C. difficile levels by day 3 of infection in antibiotic-treated mice
that received the BacMix compared to mice that received PBS
only (Fig. 5d,e). This decrease in colonization levels detected at
day 3 post-infection is comparable to colonization reductions
exhibited by a C. difficile nanT mutant strain, which is impaired
in NeuAc uptake17. These findings, together with the decreased
expression of C. difficile genes required for NeuAc catabolism
(Fig. 4d), suggest that mucosal sugar depletion is one of the
mechanisms involved in colonization resistance. Nevertheless,
we cannot rule out that mechanisms other than depletion of
these sugars may also contribute and be relevant to the observed
outcome. Our results show that the BacMix per se is not suffi-
cient to completely halt C. difficile colonization, but may con-
stitute a base for developing a more extensive combination of
organisms to provide colonization resistance by additional, dis-
tinct mechanisms. For instance, the BacMix may act in synergy
with organisms such as Lactobacillus reuteri strain 1793828 or
Clostridium scindens29,30 that inhibit C. difficile growth either by
transforming glycerol into the antimicrobial compound reuterin
in the first case, or by converting primary into secondary bile
acids in the second case. Such combinations may be the key to
completely restore resistance to C. difficile colonization. It would
also be relevant to further assess the impact of the BacMix alone
or in combination with additional organisms in other aspects of
CDI beyond colonization. The C. difficile 630 strain and the
mouse model of CDI employed here enabled us to uncover the
impact of BacMix administration on C. difficile colonization, but
to evaluate the impact of bacteriotherapy mixtures on disease
outcome, experiments with more virulent C. difficile strains (e.g.
strain VPI 10463 or R20291) together with additional animal
models of C. difficile pathogenesis (e.g. the hamster model of
CDI51) are needed.
In summary, this study extends the toolbox to identify
microbes within the gut microbiota with beneficial functions and
provides an important basis for the development of therapeutics.
Function-targeted sorting of uncultured cells enabled us to
identify the key organisms involved in a specific process (mucosal
sugar utilization) within a complex gut community. This infor-
mation was then used to formulate a mixture of organisms that
could interfere with C. difficile colonization, at least in part by
depleting available mucosal sugars from the guts of susceptible
animals. We believe that this approach provides a solid frame-
work to design targeted bacteriotherapies for the treatment of
enteric pathogens.
Methods
Ethics statement. All animal experiments were performed at the Max F. Perutz
Laboratories of the University of Vienna, Austria. All experiments were discussed
and approved by the University of Veterinary Medicine, Vienna, Austria, and
conducted in accordance with protocols approved by the Federal Ministry for
Education, Science and Research of the Republic of Austria under the license
number BMWF-66.006/0001-WF/V/3b/2016. Animals were randomized for
interventions but researchers processing the samples and analyzing the data were
aware which intervention group corresponded to which cohort of animals.
Mouse colon incubations. Three adult (6-8 weeks old) C57BL/6N mice bred at the
Max F. Perutz Laboratories, University of Vienna, under SPF conditions were
sacrificed per experiment, and their colon was harvested anaerobically (85% N2,
10% CO2, 5% H2) in an anaerobic tent (Coy Laboratory Products, USA). Contents
from each colon were suspended in 7.8 mL of 50% D2O-containing PBS and
homogenized by vortexing. Similar conditions have been successfully applied in the
past to monitor activity of individual cells in gut communities without causing
major changes in the activity of individual community members34. The homo-
genate was left to settle for 10 min, and the supernatant was then distributed into
glass vials and supplemented with different concentrations of mucosal sugar
monosaccharides, glucose, mucin or nothing (no-amendment control) (all
amendment chemicals were from Sigma-Aldrich, except D(+)-galactose which was
purchased from Carl Roth GmbH) (Fig. 1a,c). After incubation for 6 h at 37 °C,
glycerol was added (to achieve a final concentration of 20% (v/v) of glycerol in the
microcosms) and the vials were crimp-sealed with rubber stoppers and stored at
−80 °C until further processing. Prior to glycerol addition, subsamples of the
biomass were collected, pelleted and supernatants stored at −80 °C for HILIC LC-
MS/MS measurements. Pellets were washed with PBS to remove D2O and were
fixed in 3% formaldehyde for 2 h at 4 °C and stored in 50% PBS/50% ethanol
solution at −20 °C until further use. A total of three biological replicates were
established using starting material pooled from three animals each (experiments
MonoA, MonoB and MonoC). For the MonoA and MonoB experiments, micro-
cosms were established for all the different concentrations of monosaccharides
tested (Fig. 1c), while for MonoC only the highest concentrations of mono-
saccharides tested in incubations MonoA and MonoB were supplemented. Note
that analysis of mucin-amended sorted fractions has been published elsewhere35.
Since mucin contains all the monosaccharides included in this study, it constitutes
an important control, and therefore we processed the sequencing data from mucin
sorts in parallel with our samples and included it in our analyses (Fig. 2).
Mass spectrometric analysis of mucosal monossaccharides. Hydrophilic
interaction chromatography (HILIC) LC-MS/MS was used for the measurement of
mucosal monosaccharides in microcosm supernatants. Frozen samples were
thawed at room temperature and centrifuged for 10 min at 18.000 × g and 4 °C.
Supernatants were then diluted 1:50 with acetonitrile:water (1:1; v/v) and a volume
of 3 µl was injected onto the chromatographic column. The UHPLC system
(UltiMate 3000, Thermo Scientific) was coupled to a triple quadrupole mass
spectrometer (TSQ Vantage, Thermo Scientific) by an electrospray ionization
interface. Hydrophilic interaction chromatographic separation was realized on a
Luna aminopropyl column (3 µm, 150 × 2mm; Phenomenex, Torrance, CA) at a
flow rate of 0.25 ml/min. Eluent A consisted of 95% water and 5% acetonitrile with
20 mM ammonium acetate and 40 mM ammonium hydroxide as additives and
eluent B of 95% acetonitrile and 5% water. A multi-step gradient was optimized as
follows: 100% B until minute 2, then linearly decreased to 80% B until minute 20
and further to 0% B until minute 25. The column was kept at 0% B for 4 min before
it was equilibrated for 5 min at the initial conditions. The column temperature was
maintained at 40 °C. The mass spectrometer was operated in multiple reaction
monitoring (MRM) mode. Electrospray ionization (ESI) was optimized as follows:
spray voltage 2800 V (positive mode) and 3000 V (negative mode); vaporizer
temperature 250 °C; sheath gas pressure 30 Arb; ion sweep gas pressure 2 Arb;
auxiliary gas pressure 10 Arb; capillary gas temperature 260 °C. Mass spectrometric
parameters were optimized by direct injection and are reported together with the
retention times of individual sugars in Supplementary Table 6. Spiking experiments
and regular quality control checks were conducted to evaluate and ensure the
systems’ proper performance.
Confocal Raman microspectroscopy and spectral processing of fixed samples.
Formaldehyde-fixed samples were spotted on aluminum-coated slides (Al136; EMF
Corporation) and washed by dipping into ice-cold Milli-Q (MQ) water (Millipore)
to remove traces of buffer components. Individual cells were observed under a
100×/0.75 NA microscope objective. Single microbial cell spectra were acquired
using a LabRAM HR800 confocal Raman microscope (Horiba Jobin-Yvon)
equipped with a 532-nm neodymium-yttrium aluminum garnet (Nd:YAG) laser
and either 300 grooves/mm diffraction grating. Spectra were acquired in the range
of 400–3200 cm−1 for 30 s with 2.18 mW laser power. Raman spectra were
background-corrected using the sensitive nonlinear iterative peak algorithm, and
afterwards normalized to the sum of its absolute spectral intensity34. For quanti-
fication of the degree of D substitution in CH bonds (%CD), the bands assigned to
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C–D (2040–2,300 cm−1) and C–H (2,800–3,100 cm−1) were calculated using
integration of the specified region34.
Raman-activated cell sorting. For RACS of D-labeled cells, 100 μl of glycerol-
preserved microcosms containing non-fixed cells were pelleted, washed once with
MQ water containing 0.3 M glycerol and finally resuspended in 0.5 ml of 0.3 M
glycerol in MQ water. Cell sorting was performed in a fully automated manner
using a Raman microspectroscope (LabRAM HR800, Horiba Scientific, France)
combined with optical tweezers and a polydimethylsiloxane (PDMS) microfluidic
sorter. The optical tweezers (1,064 nm Nd:YAG laser at 500 mW) and Raman
(532 nm Nd:YAG laser at 45 mW or 80 mW; see below) laser were focused at the
same position of the interface between the sample and sheath streams using a single
objective (63x, 1.2 NA water-immersion, Zeiss). The in-house software based on
the graphical user interface (GUI; written in MATLAB) detected the single-cell
capture and its deuterium labeling status by calculating the cell index (PC= I1,620-
1,670/Ifluid,1,620-1,670; where I is the integrated intensity between the indicated
wavenumbers) and the labeling index (PL= I2040-2300/I1850-1900), respectively. We
did not detect a significant change in the C–D peak region (2040–2300 cm−1) due
the presence of 0.3 M of glycerol in the sorting fluid (added to minimize the
osmotic stress when the sample was re-suspended for the RACS) (Supplementary
Fig. 2a). Other spectral regions (e.g., <1500 cm−1 and >2700 cm−1) were slightly
affected, but the sorting algorithm employed and the parameters described above
take these small changes into account: the cell index PC (I1620–1670/Ifluid,1620–1670)
used to detect single-cell capture was calculated by comparing the Raman intensity
of cells measured in real-time to that of the working fluid measured in the cali-
bration (conducted before the actual sorting). The threshold value for PL
(I2040–2300/I1850–1900) was chosen based on the measurement of the control sample
(i.e., sample incubated in non-D2O-containing medium). We used two software
versions, each of which uses 45 mW (version 1) and 80 mW (version 2) Raman
laser powers, respectively. The second version operates with higher power based on
the addition of a laser shutter that blocks the Raman laser while the cells are being
translocated, reducing the laser-induced damage on the cell. This version allows
shorter acquisition times to be employed, and therefore higher throughput of the
platform. The laser power for each version was chosen based on visual inspection
of captured cells as described35. For the NeuAc and GlcNAc-amendment sorts
(version 1, since version 2 was not yet available), PC value was calculated from cell
spectra acquired for 2 s at the “capture location”, while the PL value was calculated
from spectra obtained with a 5 s exposure time at the “evaluation location”. Fucose,
GalNAc, and galactose-supplemented sorts were performed with version 2 of the
platform, which in the meantime became available, significantly reducing sorting
times. For these sorts both PC and PL values were simultaneously measured at the
“capture location” with a 0.3 s exposure time. Only the D-labeled cells were
translocated to the ‘evaluation location’ and immediately released. In order to
determine the threshold PL above which a cell from the microcosms should be
considered D-labeled (and therefore selected and sorted), cells from glucose-
supplemented microcosms incubated in the absence or presence of D (0% versus
50% D2O in the microcosms) were run on the platform prior to sorting. The
threshold PL number can vary across microcosms due to different microbial
compositions and/or physiological status of cells present in the starting material, as
well as due to different laser powers employed. Therefore we determined the PL
threshold separately for both MonoA and MonoB incubations using both 45 and
80 mW laser power. Nevertheless, we reached a PL threshold of 6.19 for all sets of
conditions and incubations tested (Supplementary Fig. 2b). We speculate this was
due to the identical conditions used in both incubations and the fact that both
communities have a similar microbial composition (Fig. 1e). To test the sorting
accuracy of the platform on our samples, the negative control (H2O, glucose-
supplemented microcosm) was re-run in the platform and sorted using the adopted
threshold (PL= 6.19) (Supplementary Table 1). As expected, no cells were con-
sidered labeled by the platform under these conditions. Sorted fractions were
nevertheless collected and sequenced as controls.
Preparation of 16S rRNA gene amplicon libraries and 16S rRNA gene
sequence analyses. DNA extracted from the mouse colon microcosms or from
mouse fecal pellets using a phenol-chloroform bead-beating protocol52 was used as
a template for PCR. PCR amplification was performed with a two-step barcoding
approach53. In the first-step PCR, the 16S rRNA gene of most bacteria was targeted
using oligonucleotide primers (Supplementary Table 7) containing head adaptors
(5′-GCTATGCGCGAGCTGC-3′) in order to be barcoded in a second step PCR53.
Barcode primers consisted of the 16 bp head sequence and a sample-specific 8 bp
barcode from a previously published list at the 5′ end. The barcoded amplicons
were purified with the ZR-96 DNA Clean-up Kit (Zymo Research, USA) and
quantified using the Quant-iT PicoGreen dsDNA Assay (Invitrogen, USA). An
equimolar library was constructed by pooling samples, and the resulting library was
sent for sequencing on an Illumina MiSeq platform at Microsynth AG (Balgach,
Switzerland). Paired-end reads were quality-filtered and processed using QIIME
153,54. Reads were then clustered into operational taxonomic units (OTUs) of 97%
sequence identity and screened for chimeras using UPARSE implemented in
USEARCH v8.1.186155. OTUs were classified using the RDPclassifier v2.1256 as
implemented in Mothur v1.39.557 using the Silva database v13258. Sequencing
libraries were rarefied and analyzed using the vegan package (v2.4-3) of the soft-
ware R (https://www.r-project.org/, R 3.4.0).
Sequencing of mouse gut isolates. Bacteroides sp. Isolate FP24 was isolated from
YCFA agar plates (DSMZ medium 1611- YCFA MEDIUM (modified)) by plating
ten-fold dilution series of a microcosms supplemented with 2 mg/ml of NeuAc
(experiment MonoB)). Escherichia sp. isolate FP11 and Anaerotruncus sp. isolate
FP23 were isolated from C. difficile minimal medium17 agar plates supplemented
with 0.25% NeuAc or 0.25% GlcNAc by plating ten-fold dilution series of a
microcosms supplemented with 2 mg/ml of NeuAc (experiment MonoB) or of a
microcosms supplemented with 5 mg/ml of GlcNAc (experiment MonoA),
respectively. Colonies were re-streak on the same medium plates until complete
purity. Pure colonies were grown overnight in 10 mL of BHI medium (Brain heart
infusion at 37 g per liter of medium) supplemented with: yeast extract, 5 g;
Na2CO3, 42 mg; cysteine, 50 mg; vitamin K1, 1 mg; hemin, 10 µg. DNA was
extracted from pelleted biomass using the QIAGEN DNAeasy Tissue and Blood kit
(Qiagen, Austin, TX, USA) according to the manufacturer´s instructions.
Sequencing libraries were prepared using the NEBNext® Ultra™ II FS DNA kit
(Illumina) and sequenced in an Illumina MiSeq platform with 300-bp paired-end
sequencing chemistry (Joint Microbiome Facility, University of Vienna and
Medical University of Vienna, Austria). Reads were quality trimmed with the
bbduk option of BBmap (v 34.00) at phrad score 15. Quality-trimmed reads were
assembled with SPAdes (v 3.11.1)59. For isolate FP11, assembled reads were sub-
sequently, iteratively (n= 6) reassembled with SPAdes using contigs of >1 kb from
the previous assembly as “trusted contigs” for input and iterating kmers from 11 to
121 in steps of 10. CheckM (v1.0.6) assessment60 of these genomes is summarized
in Supplementary Data 1.
Mini-metagenome sequencing and genomic analyses. Labeled RACS cells were
collected into PCR tubes, lysed and subjected to whole-genome amplification using the
Repli-g Single Cell Kit (QIAGEN), according to the manufacturer’s instructions.
Shotgun libraries were generated using the amplified DNA from WGA reactions
(sorted fractions) or DNA isolated using the phenol-chloroform method (initial
microcosms) as a template and Nextera XT (Illumina) reagents. Libraries were
sequenced with a HiSeq 3000 (Illumina) in 2 × 150 bp mode at the Biomedical
Sequencing Facility, Medical University of Vienna, Austria. The sequence reads were
quality trimmed and filtered using BBMap v34.00 (https://sourceforge.net/projects/
bbmap/). The remaining reads were assembled de novo using SPAdes 3.11.159 in
single-cell mode (k-mer sizes: 21, 35, 55). Binning of the assembled reads into
metagenome-assembled genomes (MAGs) was performed with MetaBAT 2 (v2.12.1)61
using the following parameters: minContig 2000, minCV 1.0, minCVSum 1.0,
maxP 95%, minS 60, and maxEdges 200. The quality and contamination of all
MAGs were checked with CheckM 1.0.660 (Supplementary Data 1). MAGs >200 kb
obtained from all samples were compared and de-replicated using dRep 1.4.362.
Automatic genome annotation of contigs >2 kb within each de-replicated MAG
was performed with RAST 2.063. Taxonomic classification of each MAG was
obtained using GTDB-Tk64 (v0.1.3, gtdb.ecogenomic.org/).
The relative abundance of each MAG on the initial microcosms was calculated
based on metagenomic coverage. Filtered reads from each sequenced microcosm
were mapped competitively against all retrieved MAGs using BBMap (https://
sourceforge.net/projects/bbmap/). Read coverage was normalized by genome size
and relative abundances of each genome in each sample were calculated based on
the formula: covA= (bpA/gA)/(bpT/gT), where covA is the relative abundance of
MAG A on a particular sample, bpA is the number of base pairs from reads
matching MAG A, gA is the genome length of MAG A, bpT is the total number of
base pairs from reads matching all MAGs recovered from that particular sample
and gT is the sum of all MAGs genome lengths.
For determination of the presence of encoded enzymes for catabolism of mucin
monosaccharides among MAGs, predicted protein sequences from recovered
MAGs were subject to local BLASTP analyses65, against a custom database. The
database was composed of all enzymes involved initial hydrolysis and catabolism of
mucosal sugar monosaccharides (Supplementary Data 2), which were previously
curated from a total of 395 human gut bacteria15. A strict e-value threshold of
10−50 was used for all BLASTP analyses. During initial setup of the analysis
pipeline, functional assignments of proteins that gave positive BLASTP hits were
manually verified by examining annotations from RAST 2.0 and by performing
BLASTP analyses against the NCBI-nr database (NCBIBlast 2.2.26).
To verify the enrichment of a selected dataset of mucin-degrading enzymes35 in
the assemblies derived from sorted fractions, BLASTX analyses of scaffolds from
each fraction as well as from the initial microcosms metagenomes (unsorted) were
performed against the selected mucin-degrading enzyme sequences15
(Supplementary Table 3). An e-value threshold of 10−50 was also used for all
BLASTX analyses.
Phylogenomic analyses. A concatenated marker alignment of 34 single-copy
genes was generated for all MAGs using CheckM 1.0.660 and the resulting align-
ment was used to calculate a tree with the approximate maximum-likelihood
algorithm of FastTree 2.1.1066. Phylogenomic trees were visualized and formatted
using iTOL v4 (https://itol.embl.de/). In order to identify the closest relative for
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each MAG, the query MAG and close reference genomes (based on the generated
phylogenomic tree) were compared using dRep 1.4.362. Compared genomes with a
whole-genome-based average nucleotide identity (ANIm) >99%39 were considered
to be the same population genome.
High-resolution mass spectrometric analyses. Glycerol-preserved biomass
(150 μL) from microcosm incubations was pelleted and suspended in 50 μL of lysis
buffer (1% sodium dodecyl sulfate (SDS), 10 mM TRIS base, pH 7.5). Protein
lysates were subjected to SDS polyacrylamide gel electrophoresis followed by in-gel
tryptic digestion. Proteins were stained with colloidal Coomassie Brilliant Blue G-
250 (Roth, Kassel, Germany) and detained with Aqua dest. Whole protein bands
were cut into gel pieces and in-gel-digestion with trypsin 30 µL (0.005 µg/µL) was
performed overnight. Extracted peptides where dried and resolved in 0.1% formic
acid and purified by ZipTip® treatment (EMD Millipore, Billerica, MA, USA).
In total, 5 µg of peptides were injected into nanoHPLC (UltiMate 3000
RSLCnano, Dionex, Thermo Fisher Scientific), followed by separation on a C18-
reverse phase trapping column (C18 PepMap100, 300 µm × 5mm, particle size
5 µm, nano viper, Thermo Fischer Scientific), followed by separation on a C18-
reverse phase analytical column (Acclaim PepMap® 100, 75 µm × 25 cm, particle
size 3 µm, nanoViper, Thermo Fischer Scientific). Mass spectrometric analysis of
eluted peptides where performed on a Q Exactive HF mass spectrometer (Thermo
Fisher Scientific, Waltham, MA, USA) coupled with a TriVersa NanoMate
(Advion, Ltd., Harlow, UK) source in LC chip coupling mode. LC Gradient,
ionization mode and mass spectrometry mode were performed as described
before67. Briefly, peptide lysate were injected into a Nano-HPLC and trapped in a
C18-reverse phase column (Acclaim PepMap® 100, 75 µm × 2 cm, particle size
3 µM, nanoViper, Thermo Fisher) for 5 min. Peptide separation was followed by a
two-step gradient in 90 min from 4 to 30% of B (B: 80% acetonitrile, 0.1% formic
acid in MS-grade water) and then 30 min from 30 to 55% of B. The temperature of
the separation column was set to 35 °C and the flow rate was 0.3 µL/min. The
eluted peptides were ionized and measured. The MS was set to a full MS/dd-MS2
mode scan with positive polarity. The full MS scan was adjusted to 120,000
resolution, the automatic gain control (AGC) target of 3 × 106 ions, maximum
injection time for MS of 80 s and a scan range of 350 to 1550m/z. The dd-MS2 scan
was set to a resolution of 15,000 with the AGC target of 2 × 105 ions, a maximum
injection time for 120 ms, TopN 20, isolation window of 1.6m/z, scan range of 200
to 2000m/z and a dynamic exclusion of 30 s.
Raw data files were converted into mzML files and searched with MS-GF+
against a database obtained from microcosm metagenomes composed of 276,284
predicted protein-encoding sequences. The following parameters were used for
peptide identification: enzyme specificity was set to trypsin with one missed
cleavage allowed using 10 ppm peptide ion tolerance and 0.05 Da MS/MS
tolerance. Oxidation (methionine) and carbamidomethylation (cysteine) were
selected as modifications. False discovery rates (FDR) were determined with the
node Percolator68. Proteins were considered as identified when at least one unique
peptide passed a FDR of 5%.
The MetaProSIP toolshed69 embedded in the Galaxy framework70 (v2.3.2,
http://galaxyproject.org/) was used to identify the incorporation of stable isotopes
into peptides. MetaProSIP calculates the relative isotope abundance (RIA) on
detected isotopic mass traces (m/z tolerance of ±10 ppm, intensity threshold of
1000, and an isotopic trace correlation threshold of 0.7).
In vitro growth experiments. A. muciniphila strain Muc (DSM 22959), Ruthe-
nibacterium lactatiformans strain 585-1 (DSM 100348) and Alistipes timonensis
strain JC136 (DSM 25383) were obtained from DSMZ. Muribaculum intestinale
strain YL27 (DSM 28989) was kindly provided by Prof. Bärbel Stecher (Max-von-
Pettenkofer Institute, LMU Munich, Germany). Bacteroides sp. FP24 was isolated
from YCFA agar plates (DSMZ medium 1611-YCFA MEDIUM (modified)). All
strains were grown in reduced A II medium71 consisting of (per liter of medium):
BHI, 18.5 g; yeast extract, 5 g; trypticase soy broth, 15 g; K2HPO4, 2.5 g; hemin,
10 µg; glucose, 0.5 g; Na2CO3, 42 mg; cysteine, 50 mg; menadione, 5 µg; fetal calf
serum (complement-inactivated), 3% (vol/vol). For A. muciniphila cultivation, the
growth medium was supplemented with 0.025% (w/v) of mucin. C. difficile was
grown in BHI medium (37 g per liter of medium) supplemented with: yeast extract,
5 g; Na2CO3, 42 mg; cysteine, 50 mg; vitamin K1, 1 mg; hemin, 10 µg. All strains
were grown at 37 °C under anaerobic conditions until stationary phase, and then
serially diluted and plated into media agar plates in order to determine the number
of viable cells present in 1 ml of stationary phase-culture. For mixed-growth
experiments, the culture volume equivalent to 1 × 106 CFU of each strain was
pelleted, cells were washed with PBS, mixed in equal proportions and finally
resuspended in 100 μl of PBS. This bacterial mixture containing a total of 5 × 106
BacMix cells was then used to inoculate 2.5 ml of A II medium (diluted two fold in
2× PBS) supplemented or not with 0.25% (10 mM) carbon source (0.125% or 4 mM
of NeuAc and 0.125% or 6 mM of GlcNAc). After 12 h, the same tube was
inoculated with 1 × 106 C. difficile CFU and bacterial growth was followed by
measuring the OD at 600 nm every hour until stationary phase. At three distinct
points of the C. difficile growth curve—lag (t12, right after C. difficile addition),
mid-exponential (t18) and early stationary phase (t21)—a sample aliquot was
collected and ten-fold dilutions were plated in a C. difficile selective medium72. This
selective medium (CCFA) includes antibiotics such as cycloserine and cefoxitn at
concentrations that are inhibitory to most gut organisms, except for C. difficile,
allowing to determine total C. difficile counts. A second aliquot was immediately
pelleted and the pellet was stored at −80 °C for RNA extraction.
Quantitative PCR of C. difficile 16S rRNA gene copy number density. DNA was
extracted from 100 mg of mouse fecal pellet using the QIAGEN DNAeasy Tissue
and Blood kit (Qiagen, Austin, TX, USA) according to the manufacturer´s
instructions, with an additional step of mechanical cell disruption by bead beating
(30 s at 6.5 m/s) right after addition of kit lysis buffer AL. Extracted DNA (2 μl) was
subjected to quantitative PCR using 0.2 μM of primers specifically targeting the C.
difficile 16S rRNA gene73 (Supplementary Table 7) and 1× SYBR green Master Mix
(Bio-Rad) in a total reaction volume of 20 μl. Standard curves were generated from
DNAs extracted from fecal pellets of SPF (uninfected) mice spiked in with different
known numbers of C. difficile cells (102, 103, 104, 105, 106, 107, and 108) as
described in Kubota et al., 2014. Amplification and detection were performed using
a CFX96™ Real-Time PCR Detection System (Bio-Rad) using the following cycling
conditions: 95 °C for 5 min, followed by 40 cycles of 95 °C for 15 s, 56 °C for 20 s,
and 72 °C for 30 s. To determine the specificity of PCR reactions, melt curve
analysis was carried out after amplification by slow cooling from 95 to 60 °C, with
fluorescence collection at 0.3 °C intervals and a hold of 10 s at each decrement.
Only assays with amplification efficiencies above 80% were considered for analysis.
RNA extraction and quantitative real-time PCR. Total nucleic acids (TNA) were
extracted from mouse fecal pellets or from in vitro cultures using a phenol-
chloroform bead-beating protocol52. RNA was purified from DNAse-treated TNA
fractions using the GeneJET Cleanup and Concentration micro kit (Thermo Fisher
Scientific). cDNA was synthesized from 0.5 μg of total RNA with 1 μl of random
hexamer oligonucleotide primers. Samples were heated for 5 min at 70 °C. After a
slow cooling, 2 μl of deoxynucleoside triphosphates (dNTP; 2.5 mM each), 40 units
of recombinant ribonuclease inhibitor (RNaseOUT) and 4 μl of reverse tran-
scription (RT) buffer were added and cDNAs were synthesized for 2 h at 50 °C
using 200 units SuperScript™ III Reverse Transcriptase (all reagents used in cDNA
synthesis were from Thermo Fisher Scientific). Real-time quantitative PCR was
performed in a 20-μl reaction volume containing 2 μl of cDNA, 1x SYBR green
Master Mix (Bio-Rad) and 0.2 μM of gene-specific C. difficile primers targeting the
following genes: DNA polymerase III PolC-type dnaF74, nanA, nanT17 and nagB
(this work; Supplementary Table 7). Amplification and detection were performed
as described above. In each sample, the quantity of cDNAs of a gene was nor-
malized to the quantity of cDNAs of the C. difficile DNA polymerase lII gene74
(dnaF). The relative change in gene expression was recorded as the ratio of nor-
malized target concentrations (threshold cycle [ΔΔCT] method75). Fold changes
were normalized to in vitro growths in C. difficile minimal medium containing
0.5% glucose17. To determine the specificity of PCR reactions, melt curve analysis
was carried out after amplification by slow cooling from 95 to 60 °C, with fluor-
escence collection at 0.3 °C intervals and a hold of 10 s at each decrement. Only
assays with amplification efficiencies above 80% were considered for analysis.
Murine in vivo adoptive transfer experiments. Female C57BL/6N 6-8 weeks old
mice (n= 33 total) were purchase from Janvier Labs. Animals were kept in isolated,
ventilated cages under specific pathogen-free conditions at the animal facility of the
Max F. Perutz Laboratories, University of Vienna, Austria, with controlled tem-
perature of 21 ± 1 °C and humidity of 50 ± 10%, in a 12-h light/dark cycle. Mice
received a standard diet (V1124-300; Ssniff, Soest, Germany) and autoclaved water
ad libitum. Mice were administered antibiotics (0.25 mg/ml clindamycin (Sigma-
Aldrich) for six days in drinking water) and subsequently assigned randomly to one
of two groups. One day following antibiotic cessation, mice from each group were
split into 3 cages (to minimize the cage effect) and each mouse received either
5,000,000 CFU of a 5-bacteria suspension (BacMix, containing equal numbers of A.
muciniphila strain Muc (DSM 22959), Ruthenibacterium lactatiformans strain 585-
1 (DSM 100348), Alistipes timonensis strain JC136 (DSM 25383), Muribaculum
intestinale strain YL27 (DSM 28989), and Bacteroides sp. isolate FP24) or vehicle
(PBS) by gavage (Fig. 5a). At the time of BacMix and BacMixC administration, the
mouse diet was switched from a standard diet (V1124-300; Ssniff, Soest, Germany)
to a isocaloric polysaccharide-deficient chow76 with sucrose but no cellulose or
starch (Ssniff, Soest, Germany). For the BacMixC adoptive transfer, each mouse
(n= 10 per group) received 5,000,000 CFU of a 3-bacteria suspension (BacMixC,
containing equal numbers of Anaerotruncus sp. isolate FP23; Lactobacillus hominis
strain DSM 23910 and of Escherichia sp. isolate FP11) or vehicle (PBS) by gavage
(Supplementary Fig. 7). One day after BacMix or BacMixC administration, mice
were challenged with 1,000,000 CFU of C. difficile strain 630 deltaErm77. A.
muciniphila, R. lactatiformans and M. intestinale were grown in reduced A II
medium (supplemented with 0.025% mucin for A. muciniphila). Anaerotruncus sp.
isolate FP23, A. timonensis and Bacteroides sp. isolate FP24 were grown in PYG
(DSMZ medium 104). Lactobacillus hominis and Escherichia sp. isolate FP11 were
grown in YCFA medium (DSMZ medium 1611). C. difficile was grown in BHI
medium (37 g per liter of medium). All bacteria were grown under anaerobic
conditions (5% H2, 10% CO2, rest N2) at 37 °C and resuspended in anaerobic PBS
prior to administration to animals. C. difficile titers were quantified in fecal samples
obtained from mice 24, 48, 72, and 120 h after infection by overnight cultivation in
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C. difficile selective agar plates72. Animals were monitored throughout the entire
experiment and weight loss was recorded.
Measurement of mucus thickness and goblet cell volume. Segments of mouse
colon (approximately 10 mm long) were fixed in 2% PFA in phosphate-buffered
saline (PBS) for 12 h at 4 °C. Samples were washed with 1× PBS and then stored in
70% ethanol at 4 °C until embedding. For embedding, samples were immersed in 3
changes of xylene for 1 h each, then immersed in 3 changes of molten paraffin wax
(Paraplast, Electron Microscopy Sciences) at 56–58 °C for one hour each. Blocks
were allowed to harden at room temperature. Sections were cut to 4 μm thickness
using a Leica microtome (Leica Microsystems) and were floated on a water bath at
40–45 °C, then transferred to slides, dried, and stored at room temperature. In
preparation for staining, slides were de-paraffinized by heating at 60 °C for 30 min
followed by immersion in 2 changes of xylene for 5 min each, then in 2 changes of
100% ethanol for 1 minute each, then rehydrated through 80%, and 70% ethanol
for 1 minute each. Slides were then dipped in water, drained, air-dried and a drop
of Alcian Blue stain (Sigma Aldrich) applied on top. Samples were incubated with
Alcian Blue for 20 min at room temperature and then washed in water to remove
the excess of stain. Samples were mounted in Vectashield Hardset™ Antifade
Mounting Medium (Vector Laboratories) and visualized using a Leica Confocal
scanning laser microscope (Leica TCS SP8X, Germany). For measurements of the
width of the mucus layer and determination of goblet cell volume per crypt, ImageJ
software (https://imagej.nih.gov/ij/, 1.48 v) was used.
Histology and histopathological scoring. Mouse colons were flushed with cold
PBS to remove all contents, and the entire colon was rolled into Swiss rolls. The
tissues were fixed in 2% PFA for 12 h at 4 °C and then washed in 1x PBS and
transferred to 70% ethanol until embedding. Swiss rolls were embedded in the same
manner as described above for segments of mouse colon. Paraffin-embedded, PFA
fixed tissues were sectioned at 4.5 μm. Tissue sections were de-paraffinized and
hematoxylin and eosin stained (Mayer’s Hematoxylin, Thermo Scientific; Eosin 1%,
Morphisto, Germany). Histopathological analyses were performed using a semi-
quantitative scoring system78 that evaluated the severity of crypt damage and cellular
infiltration, epithelial erosion and tissue thickening using a severity score from 0 to 3
(0= intact, 1=mild, 2=moderate, 3= severe), and those scores were multiplied by
a score for percent involvement (0= 0%, 1= 1–25%, 2= 26–50%, 3= 50–100%). A
trained and blinded scientist performed the scoring. Representative images were
acquired using an Olympus CKX53 microscope and Olympus SC50 camera.
Quantification of C. difficile toxin TcdB. Levels of TcdB in mouse colon contents
were quantified relative to a standard curve of purified TcdB using an ELISA assay
kit (“Separate detection of C. difficile toxins A and B”, TGC Biomics) according to
the manufacturer’s instructions. For each mouse, approximately 10 mg of colon
content were used in the assay. The limit of detection for the assay in our con-
ditions was determined to be 5.14 ng of TcdB per gram of colon content (Sup-
plementary Fig. 8c). One of the mice from the BacMix group had toxin levels below
the detection limit and was therefore excluded from analysis.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon request. 16S rRNA gene sequence data have been deposited in the NCBI
Sequence Read Archive (https://www.ncbi.nlm.nih.gov/sra) under SRP226368.
Metagenomic data have been deposited in the NCBI Sequence Read Archive under
SRP227836 and SRP144778 (for mucin amendment metagenomic data35). RACS MAGs
have been deposited as whole-genome shotgun projects at DDBJ/ENA/GenBank (https://
www.ncbi.nlm.nih.gov/genbank/) under the accessions WSLP00000000-
WSNN00000000 (Supplementary Table 8). The mass spectrometry proteomic data has
been deposited to the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE79 partner repository with the dataset identifier
PXD015215. Source data are provided with this paper.
Code availability
All of the custom codes used in this study can be accessed upon reasonable request from
the corresponding author. MATLAB GUI (graphical user interface) and code used in the
RACS sorting (version 1; RACS_ver.1) is available at https://github.com/harubang2/
MATLAB-platform-for-Raman-activated-cell-sorting-RACS. MATLAB GUI (graphical
user interface) and code used in the RACS sorting (version 2) is available at https://
github.com/fatimapereira454/MATLAB-platform-for-Raman-activated-cell-sorting-
RACS-version2.
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